Mark de Wolf

Mark de Wolf is a dedicated Researcher in the Department of Radiology & Nuclear Medicine at Erasmus MC, focusing on advancing clinical practices in vascular interventions. His work centers on optimizing venous stent outcomes and managing complications in post-thrombotic syndrome through evidence-based approaches.

Dr. de Wolf's research spans critical areas of vascular medicine including venous stent patency evaluation, inflow disease impact analysis, and anticoagulant therapy optimization. He employs advanced statistical methodologies such as Kaplan-Meier survival analysis and log-rank tests to assess clinical outcomes, with particular emphasis on femoral vein pathology and limb symptom management. His methodological rigor bridges interventional radiology with hemostasis research.

Analysis of his recent publications reveals consistent thematic focus on venous stent durability and thrombosis prevention. The 2025 study investigates how inflow disease compromises stent patency in post-thrombotic syndrome patients, while the 2020 work establishes critical links between anticoagulant quality and in-stent thrombosis incidence. Both contributions demonstrate his expertise in translating clinical data into improved venous disease management protocols through collaborative multicenter research.